2022-2027 Global and Regional Needle-free Injection Systems Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-73749 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Needle-free Injection Systems market was valued at 170.85 Million USD in 2021 and will grow with a CAGR of 5.31% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems. Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 60% of the market. North America is the larest market, with a share over 60%. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 50%. By Market Verdors: Antares Pharma Endo International plc Inovio Pharmaceuticals Injex Pharma National Medical Products Inc (J-Tip) Recipharm European Pharma Group (InsuJet) Miracle Medical Medical International Technology (MIT) Akra Dermojet PharmaJet Portal Instruments Crossject Medical Technology MIKA MEDICAL Ferring Pharmaceuticals DAntonio Consultants International Lepu Medical TECHiJET By Types: Reusable Injector Single-use Injector By Applications: Vaccine Delivery Insulin Delivery Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Needle-free Injection Systems Market Size Analysis from 2022 to 2027 1.5.1 Global Needle-free Injection Systems Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Needle-free Injection Systems Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Needle-free Injection Systems Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Needle-free Injection Systems Industry Impact Chapter 2 Global Needle-free Injection Systems Competition by Types, Applications, and Top Regions and Countries 2.1 Global Needle-free Injection Systems (Volume and Value) by Type 2.1.1 Global Needle-free Injection Systems Consumption and Market Share by Type (2016-2021) 2.1.2 Global Needle-free Injection Systems Revenue and Market Share by Type (2016-2021) 2.2 Global Needle-free Injection Systems (Volume and Value) by Application 2.2.1 Global Needle-free Injection Systems Consumption and Market Share by Application (2016-2021) 2.2.2 Global Needle-free Injection Systems Revenue and Market Share by Application (2016-2021) 2.3 Global Needle-free Injection Systems (Volume and Value) by Regions 2.3.1 Global Needle-free Injection Systems Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Needle-free Injection Systems Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Needle-free Injection Systems Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Needle-free Injection Systems Consumption by Regions (2016-2021) 4.2 North America Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) 4.10 South America Needle-free Injection Systems Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Needle-free Injection Systems Market Analysis 5.1 North America Needle-free Injection Systems Consumption and Value Analysis 5.1.1 North America Needle-free Injection Systems Market Under COVID-19 5.2 North America Needle-free Injection Systems Consumption Volume by Types 5.3 North America Needle-free Injection Systems Consumption Structure by Application 5.4 North America Needle-free Injection Systems Consumption by Top Countries 5.4.1 United States Needle-free Injection Systems Consumption Volume from 2016 to 2021 5.4.2 Canada Needle-free Injection Systems Consumption Volume from 2016 to 2021 5.4.3 Mexico Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 6 East Asia Needle-free Injection Systems Market Analysis 6.1 East Asia Needle-free Injection Systems Consumption and Value Analysis 6.1.1 East Asia Needle-free Injection Systems Market Under COVID-19 6.2 East Asia Needle-free Injection Systems Consumption Volume by Types 6.3 East Asia Needle-free Injection Systems Consumption Structure by Application 6.4 East Asia Needle-free Injection Systems Consumption by Top Countries 6.4.1 China Needle-free Injection Systems Consumption Volume from 2016 to 2021 6.4.2 Japan Needle-free Injection Systems Consumption Volume from 2016 to 2021 6.4.3 South Korea Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 7 Europe Needle-free Injection Systems Market Analysis 7.1 Europe Needle-free Injection Systems Consumption and Value Analysis 7.1.1 Europe Needle-free Injection Systems Market Under COVID-19 7.2 Europe Needle-free Injection Systems Consumption Volume by Types 7.3 Europe Needle-free Injection Systems Consumption Structure by Application 7.4 Europe Needle-free Injection Systems Consumption by Top Countries 7.4.1 Germany Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.2 UK Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.3 France Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.4 Italy Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.5 Russia Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.6 Spain Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.7 Netherlands Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.8 Switzerland Needle-free Injection Systems Consumption Volume from 2016 to 2021 7.4.9 Poland Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 8 South Asia Needle-free Injection Systems Market Analysis 8.1 South Asia Needle-free Injection Systems Consumption and Value Analysis 8.1.1 South Asia Needle-free Injection Systems Market Under COVID-19 8.2 South Asia Needle-free Injection Systems Consumption Volume by Types 8.3 South Asia Needle-free Injection Systems Consumption Structure by Application 8.4 South Asia Needle-free Injection Systems Consumption by Top Countries 8.4.1 India Needle-free Injection Systems Consumption Volume from 2016 to 2021 8.4.2 Pakistan Needle-free Injection Systems Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Needle-free Injection Systems Market Analysis 9.1 Southeast Asia Needle-free Injection Systems Consumption and Value Analysis 9.1.1 Southeast Asia Needle-free Injection Systems Market Under COVID-19 9.2 Southeast Asia Needle-free Injection Systems Consumption Volume by Types 9.3 Southeast Asia Needle-free Injection Systems Consumption Structure by Application 9.4 Southeast Asia Needle-free Injection Systems Consumption by Top Countries 9.4.1 Indonesia Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.2 Thailand Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.3 Singapore Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.4 Malaysia Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.5 Philippines Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.6 Vietnam Needle-free Injection Systems Consumption Volume from 2016 to 2021 9.4.7 Myanmar Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 10 Middle East Needle-free Injection Systems Market Analysis 10.1 Middle East Needle-free Injection Systems Consumption and Value Analysis 10.1.1 Middle East Needle-free Injection Systems Market Under COVID-19 10.2 Middle East Needle-free Injection Systems Consumption Volume by Types 10.3 Middle East Needle-free Injection Systems Consumption Structure by Application 10.4 Middle East Needle-free Injection Systems Consumption by Top Countries 10.4.1 Turkey Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.3 Iran Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.5 Israel Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.6 Iraq Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.7 Qatar Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.8 Kuwait Needle-free Injection Systems Consumption Volume from 2016 to 2021 10.4.9 Oman Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 11 Africa Needle-free Injection Systems Market Analysis 11.1 Africa Needle-free Injection Systems Consumption and Value Analysis 11.1.1 Africa Needle-free Injection Systems Market Under COVID-19 11.2 Africa Needle-free Injection Systems Consumption Volume by Types 11.3 Africa Needle-free Injection Systems Consumption Structure by Application 11.4 Africa Needle-free Injection Systems Consumption by Top Countries 11.4.1 Nigeria Needle-free Injection Systems Consumption Volume from 2016 to 2021 11.4.2 South Africa Needle-free Injection Systems Consumption Volume from 2016 to 2021 11.4.3 Egypt Needle-free Injection Systems Consumption Volume from 2016 to 2021 11.4.4 Algeria Needle-free Injection Systems Consumption Volume from 2016 to 2021 11.4.5 Morocco Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 12 Oceania Needle-free Injection Systems Market Analysis 12.1 Oceania Needle-free Injection Systems Consumption and Value Analysis 12.2 Oceania Needle-free Injection Systems Consumption Volume by Types 12.3 Oceania Needle-free Injection Systems Consumption Structure by Application 12.4 Oceania Needle-free Injection Systems Consumption by Top Countries 12.4.1 Australia Needle-free Injection Systems Consumption Volume from 2016 to 2021 12.4.2 New Zealand Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 13 South America Needle-free Injection Systems Market Analysis 13.1 South America Needle-free Injection Systems Consumption and Value Analysis 13.1.1 South America Needle-free Injection Systems Market Under COVID-19 13.2 South America Needle-free Injection Systems Consumption Volume by Types 13.3 South America Needle-free Injection Systems Consumption Structure by Application 13.4 South America Needle-free Injection Systems Consumption Volume by Major Countries 13.4.1 Brazil Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.2 Argentina Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.3 Columbia Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.4 Chile Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.5 Venezuela Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.6 Peru Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Needle-free Injection Systems Consumption Volume from 2016 to 2021 13.4.8 Ecuador Needle-free Injection Systems Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Needle-free Injection Systems Business 14.1 Antares Pharma 14.1.1 Antares Pharma Company Profile 14.1.2 Antares Pharma Needle-free Injection Systems Product Specification 14.1.3 Antares Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Endo International plc 14.2.1 Endo International plc Company Profile 14.2.2 Endo International plc Needle-free Injection Systems Product Specification 14.2.3 Endo International plc Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Inovio Pharmaceuticals 14.3.1 Inovio Pharmaceuticals Company Profile 14.3.2 Inovio Pharmaceuticals Needle-free Injection Systems Product Specification 14.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Injex Pharma 14.4.1 Injex Pharma Company Profile 14.4.2 Injex Pharma Needle-free Injection Systems Product Specification 14.4.3 Injex Pharma Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 National Medical Products Inc (J-Tip) 14.5.1 National Medical Products Inc (J-Tip) Company Profile 14.5.2 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Specification 14.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Recipharm 14.6.1 Recipharm Company Profile 14.6.2 Recipharm Needle-free Injection Systems Product Specification 14.6.3 Recipharm Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 European Pharma Group (InsuJet) 14.7.1 European Pharma Group (InsuJet) Company Profile 14.7.2 European Pharma Group (InsuJet) Needle-free Injection Systems Product Specification 14.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Miracle Medical 14.8.1 Miracle Medical Company Profile 14.8.2 Miracle Medical Needle-free Injection Systems Product Specification 14.8.3 Miracle Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Medical International Technology (MIT) 14.9.1 Medical International Technology (MIT) Company Profile 14.9.2 Medical International Technology (MIT) Needle-free Injection Systems Product Specification 14.9.3 Medical International Technology (MIT) Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Akra Dermojet 14.10.1 Akra Dermojet Company Profile 14.10.2 Akra Dermojet Needle-free Injection Systems Product Specification 14.10.3 Akra Dermojet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 PharmaJet 14.11.1 PharmaJet Company Profile 14.11.2 PharmaJet Needle-free Injection Systems Product Specification 14.11.3 PharmaJet Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Portal Instruments 14.12.1 Portal Instruments Company Profile 14.12.2 Portal Instruments Needle-free Injection Systems Product Specification 14.12.3 Portal Instruments Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.13 Crossject Medical Technology 14.13.1 Crossject Medical Technology Company Profile 14.13.2 Crossject Medical Technology Needle-free Injection Systems Product Specification 14.13.3 Crossject Medical Technology Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.14 MIKA MEDICAL 14.14.1 MIKA MEDICAL Company Profile 14.14.2 MIKA MEDICAL Needle-free Injection Systems Product Specification 14.14.3 MIKA MEDICAL Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.15 Ferring Pharmaceuticals 14.15.1 Ferring Pharmaceuticals Company Profile 14.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Product Specification 14.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.16 DAntonio Consultants International 14.16.1 DAntonio Consultants International Company Profile 14.16.2 DAntonio Consultants International Needle-free Injection Systems Product Specification 14.16.3 DAntonio Consultants International Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.17 Lepu Medical 14.17.1 Lepu Medical Company Profile 14.17.2 Lepu Medical Needle-free Injection Systems Product Specification 14.17.3 Lepu Medical Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.18 TECHiJET 14.18.1 TECHiJET Company Profile 14.18.2 TECHiJET Needle-free Injection Systems Product Specification 14.18.3 TECHiJET Needle-free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Needle-free Injection Systems Market Forecast (2022-2027) 15.1 Global Needle-free Injection Systems Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Needle-free Injection Systems Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Needle-free Injection Systems Value and Growth Rate Forecast (2022-2027) 15.2 Global Needle-free Injection Systems Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Needle-free Injection Systems Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Needle-free Injection Systems Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Needle-free Injection Systems Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Needle-free Injection Systems Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Needle-free Injection Systems Consumption Forecast by Type (2022-2027) 15.3.2 Global Needle-free Injection Systems Revenue Forecast by Type (2022-2027) 15.3.3 Global Needle-free Injection Systems Price Forecast by Type (2022-2027) 15.4 Global Needle-free Injection Systems Consumption Volume Forecast by Application (2022-2027) 15.5 Needle-free Injection Systems Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000